Cannabis Science Supports House Minority Leader Nancy Pelosi Historic … – MarketWatch (press release)

Posted on: May 4th, 2012 by admin No Comments


COLORADO SPRINGS, Colo., May 04, 2012 (BUSINESS WIRE) –
Cannabis Science, Inc. ,
a pioneering U.S. biotech company developing pharmaceutical cannabis
products, supports House Minority Leader Nancy Pelosi D-San Francisco
Historic Statement to President Obama supporting Medical Cannabis and
the Fight for Patient Rights.

Quoted in several news sources including but not limited to the
following:

The Huffington Post:

http://www.huffingtonpost.com/2012/05/03/nancy-pelosi-medical-marijuana_n_1474854.html?ref=politics

and MediaNews Group:

http://www.ibabuzz.com/politics/2012/05/03/pelosi-has-strong-concerns-about-marijuana-raids/

House Minority Leader Nancy Pelosi D-San Francisco Historic Statement to
President Obama stated the following;

“Access to medicinal marijuana for individuals who are ill or enduring
difficult and painful therapies is both a medical and a states’ rights
issue. Sixteen states, including our home state of California and the
District of Columbia have adopted medicinal marijuana laws — most by a
vote of the people.

I have strong concerns about the recent actions by the federal
government that threatens the safe access of medicinal marijuana to
alleviate the suffering of patients in California, and undermine a
policy that has been in place under which the federal government did not
pursue individuals whose actions complied with state laws providing for
medicinal marijuana.

Proven medicinal uses of marijuana include improving the quality of life
for patients with cancer, HIV/AIDS, multiple sclerosis, and other severe
medical conditions.

I am pleased to join organizations that support legal access to
medicinal marijuana, including the American Nurses Association, the
Lymphoma Foundation of America, and the AIDS Action Council.

Medicinal marijuana alleviates some of the most debilitating symptoms of
AIDS, including pain, wasting, and nausea. The opportunity to ease the
suffering of people who are seriously ill or enduring difficult and
painful therapies is an opportunity we must not ignore.

For these reasons, I have long supported efforts in Congress to advocate
federal policies that recognize the scientific evidence and clinical
research demonstrating the medical benefits of medicinal marijuana, that
respects the wishes of the states in providing relief to ill
individuals, and that prevents the federal government from acting to
harm the safe access of medicinal marijuana provided under state law. I
will continue to strongly support those efforts.”

Dr. Robert Melamede stated, “It’s about time members of congress spoke
out in favor of democracy. The people in states like California and
Colorado have spoken through their ballots, the very basis of democracy.
This is a presidential election year. As soon as the voting public
demands medical marijuana as a condition for election, things will
rapidly change. We are not surprised by Nancy Pelosi’s statement in view
of the low approval ratings that our politicians have. We expect to
continue to see more and more politicians come out in favor of the
Medical Cannabis industry over the next few months. Let’s face it,
prohibition and its associated black market is a source of funding for
terrorism and therefore should be illegal.

Our internal models suggest that the medical cannabis industry may lower
unemployment by 11.6% or more and increase GDP. The Cannabis Industry
can help our great country while at the same time help people with
Cancer and help soldiers with PTSD. All of these topics are election
issues, which tie into the Medical Cannabis Industry and should have a
positive impact on Cannabis Science.”

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade
medical marijuana research and development. The Company works with world
authorities on phytocannabinoid science targeting critical illnesses,
and adheres to scientific methodologies to develop, produce and
commercialize phytocannabinoid-based pharmaceutical products. In sum, we
are dedicated to the creation of cannabis-based medicines, both with and
without psychoactive properties, to treat disease and the symptoms of
disease, as well as for general health maintenance.

Forward Looking Statements; This Press Release includes forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Act of 1934. A statement
containing works such as “anticipate,” “seek,” intend,” “believe,”
“plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may
be deemed “forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. Some or all of the events or
results anticipated by these forward-looking statements may not occur.
Factors that could cause or contribute to such differences include the
future U.S. and global economies, the impact of competition, and the
Company’s reliance on existing regulations regarding the use and
development of cannabis-based drugs. Cannabis Science, Inc. does not
undertake any duty nor does it intend to update the results of these
forward-looking statements.

SOURCE: Cannabis Science, Inc.


        Cannabis Science
        Robert Kane
        Vice President of Investor Relations
        rkane@cannabisscience.com
        561-234-6929
        or
        Dr. Robert Melamede, Ph.D.
        President 

www.cannabisscience.com            info@cannabisscience.com
        1-888-889-0888

Copyright Business Wire 2012

See original here: Cannabis Science Supports House Minority Leader Nancy Pelosi Historic … – MarketWatch (press release)

Raspberry Ketone Side Effect

Tags: , , , , , , , , ,

Leave a Reply

PO Box 15213, Scottsdale, AZ 85267, (602) 315-8808